Novel green synthesis and antioxidant, cytotoxicity, antimicrobial, antidiabetic, anticholinergics, and wound healing properties of cobalt nanoparticles containing Ziziphora clinopodioides Lam leaves extract.

The aim of the experiment was a green synthesis of cobalt nanoparticles from the aqueous extract of Ziziphora clinopodioides Lam (CoNPs) and assessment of their cytotoxicity, antioxidant, antifungal, antibacterial, and cutaneous wound healing properties. The synthesized CoNPs were characterized using different techniques including UV-Vis., FT-IR spectroscopy, X-ray diffraction (XRD), energy dispersive X-ray spectrometry (EDS), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). According to the XRD analysis, 28.19 nm was measured for the crystal size of NPs. TEM and SEM images exhibited a uniform spherical morphology and average diameters of 29.08 nm for the biosynthesized nanoparticles. Agar diffusion tests were done to determine the antibacterial and antifungal characteristics. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC) were specified by macro-broth dilution assay. CoNPs indicated higher antibacterial and antifungal effects than many standard antibiotics (p ≤ 0.01). Also, CoNPs prevented the growth of all bacteria at 2-4 mg/mL concentrations and removed them at 2-8 mg/mL concentrations (p ≤ 0.01). In the case of antifungal effects of CoNPs, they inhibited the growth of all fungi at 1-4 mg/mL concentrations and destroyed them at 2-16 mg/mL concentrations (p ≤ 0.01). The synthesized CoNPs had great cell viability dose-dependently and indicated this method was nontoxic. DPPH free radical scavenging test was done to assess the antioxidant potentials, which revealed similar antioxidant potentials for CoNPs and butylated hydroxytoluene. In vivo experiment, after creating the cutaneous wound, the rats were randomly divided into six groups: untreated control, treatment with Eucerin basal ointment, treatment with 3% tetracycline ointment, treatment with 0.2% Co(NO3)2 ointment, treatment with 0.2% Z. clinopodioides ointment, and treatment with 0.2% CoNPs ointment. These groups were treated for 10 days. For histopathological and biochemical analysis of the healing trend, a 3 × 3 cm section was prepared from all dermal thicknesses at day 10. Use of CoNPs ointment in the treatment groups substantially raised (p ≤ 0.01) the wound contracture, hydroxyl proline, hexosamine, hexuronic acid, fibrocyte, and fibrocytes/fibroblast rate and remarkably decreased (p ≤ 0.01) the wound area, total cells, neutrophil, and lymphocyte compared to other groups. In conclusion, CoNPs can be used as a medical supplement owing to their non-cytotoxic, antioxidant, antibacterial, antifungal, and cutaneous wound healing effects. Additionally, the novel nanoparticles (Co(NO3)2 and CoNPs) were good inhibitors of the α-glycosidase, and cholinesterase enzymes.

Introduction

Nanotechnology and nanoscience are the study and application of extremely small things and can be used across all the other science fields, such as biology, chemistry, physics, materials science, and engineering[1]. Nanotechnology are based on nanoparticles, particles with a 3D structure and a size of 1–100 nm. These materials are available in various sizes and shapes such as crystal, spherical, needle, and rod forms[1]. Different physical, chemical, and biological methods are used to produce nanoparticles. Use of physical methods requires high temperature, pressure, and cost. On the other hand, most chemical methods use chemicals that are toxic and hazardous to the environment and biological systems. Another problem of using this method is the production of toxic products[2]. Hence, there is an increasing need to discover a highly efficient and inexpensive method free of toxins and environmental damage. The biological method is one of the methods that is increasingly being used for the production of nanoparticles[2]. There is a bulky list of sources used for the biological production of metal nanoparticles, including plants and plant extracts[3]. Recently, plants have been increasingly used for the synthesis of nanoparticles. In general, photosynthesis of nanoparticles by plants has many advantages. In photosynthesis of nanoparticles by plant extracts, water is used as a solvent, which is free of risk[4]. Biosynthesis of nanoparticles by plant extracts is very easy and does not require specific conditions needed in physical and chemical methods. Plant extracts have a higher reduction potential than microbial culture media, thereby requiring less time for the formation of nanoparticles.5 The contamination created by biosynthesis of nanoparticles by plant extracts is less than other methods and is approximately zero. Therefore, the biosynthesis of nanoparticles by plant extracts has fewer environmental and is more environmentally friendly[4,5]. However, the production speed, quality, and other characteristics of the nanoparticles produced by plant extracts depend on factors such as nature of plant extract, the concentration of the extract, salt concentration, pH, temperature, and duration of the reaction[6,7]. In previous studies indicated that metal nanoparticles of plant extract have strong potentials in the treatment of bacterial, fungal, and skin diseases[8-10].

Cutaneous wound healing is a dynamic, complex, and regular response to impairment that requires the interaction of different types of cells, structural proteins, growth factors, and proteinases[11]. The basic principles of cutaneous wound healing are the minimization of tissue damage, adequate blood supply, oxygenation, proper diet, humid environment to create anatomic integrity, and function of the affected site[12]. The cutaneous wound healing process includes accumulation of platelets, coagulation, inflammatory response to damage, changing the underlying materials, angiogenesis, and re-epithelization[12]. Inflammation is a normal phenomenon in the wound healing process and is important for the elimination of the contaminating microorganisms. Prolonged inflammation occurs in the absence of effective decontamination. When microbial cleaning is incomplete, bacteria and endotoxins can prolong the pro-inflammatory cytokines as well as the inflammatory phase[13]. Subcutaneous cells begin to make collagen following injury and regenerate the epithelial cells. Hence, it is therapeutically important to discover medicines to accelerate the regeneration of dermis and epidermis against skin injuries[14]. In recent years, the use of chemicals has encouraged the researchers to conduct many studies on the use of traditional and herbal medicines. These studies have revealed that natural drugs are the only treatment modality in some cases, and the compounds available in them have been used in pharmaceutical industries[15]. Since no definitive drug has been introduced for wound healing, it is necessary to perform studies on the effects of herbal drugs and their metal nanoparticles on cutaneous wound healing[15].

Iran has experimental plants that are widely distributed throughout the country, particularly in Kermanshah province, west of Iran (geographical coordinates: 34.3277°N and 47.0778°E)[16-19]. They have been the foundation for inhibition and treatment of experimental a[20-24]. One of the most important herbal medicines that are widely used is Ziziphora clinopodioides Lam. It belongs to Ziziphora genus and Lamiaceae family with the Persian name of kakuti-e kuhi is a perennial plant. In Iran, several hundred species in 49 genera of the Lamiaceae family are scattered[25,26]. Z. clinopodioides is used in Iranian traditional medicine for treatment of gastrointestinal disorders, common cold, and inflammations is a member of Labiatae family[25]. Various properties such as antifungal[27], antibacterial[26,28], anti-inflammatory[29], and antioxidant[28,30] have been revealed as the effects of this plant. It has chemical components including flavonoids, α and β pinen, terpenoides, thymol, piperitenone, sis-isopulegone, pulegone, and cineol[26,28,31,32]. According to these compounds, it can be having notable therapeutical effects against various diseases. Due to our ongoing interest on the biosynthesis of metal nanoparticles and heterogeneous catalysts, we wish to report for the first time, green synthesis, detailed morphological, structural, and its catalytic applications of CoNPs synthesized by Z. clinopodioides leaves. CoNPs have synthesized with plant extract having the ecofriendly polyphenol which acts as a reducing agent and a capping agent. Also, considering the therapeutical effects of Z. clinopodioides, we made an attempt to study the cytotoxicity, antioxidant, antibacterial, antifungal, and cutaneous wound healing effects of CoNPs.

Experimental

Materials

All materials were obtained from Sigma Aldrich chemicals.

Extraction of Z. clinopodioides leaves aqueous extract

Z. clinopodioides was collected from Kermanshah city in the west of Iran (Fig. 1).

Figure 1

Image of Z. clinopodioides.

After complete drying of Z. clinopodioides leaves in the dark without humidity for one week, the obtained material was powdered. Of the powder, 200 g was weighed, mixed with 2000 mL (1/10weight/volume ratio) distilled water, heated at 45 °C, and stirred for 2 h. It was then kept at ambient temperature for 24 h. Next, the extract was filtered with Whatman paper #2. The primary extract was fed into a vacuum distillation apparatus (a rotary machine with a vacuum pump), and the solvent was evaporated at 40 °C for 1 h, yielding the condensed extract. To prepare the powder of the extract, the condensed solution was put in the oven for 48 h at 40 °C, and the obtained substance was lyophilized[33-35].

Preparation, synthesis and chemical characterization of CoNPs

Biosynthesis of cobalt nanoparticles was carried out according to the previous studies with some modification[36,37]. Firstly, 2.5 g of plant extract was dissolved in 62.5 mL of deionized/distilled water, then 30 mL of Co(NO3)2·6H2O with a concentration of 30 mM was added to the solution. The mixture was refluxed for 90 min at 60 °C. Then 5 mL of NaOH 2% was slowly added to the mixture during the reaction time. The color of the solution was changed to brown color. In the next step, the mixture was centrifuged at 6,000 rpm for 15 min. Finally, the residue was dried in an oven for 3 h at 50 °C. The obtained brown powder was kept in a vial for chemical characterization and biological activities.

Different techniques were used to characterize the synthesized CoNPs. The methods include UV–Vis., FT-IR spectroscopy; XRD, SEM, EDS, and TEM techniques. Different parameters of the nanoparticle, such as shape, particle size, fractal dimensions, crystallinity and surface area are obtained by these techniques. The UV–Vis. spectra were obtained by a PhotonixAr 2015 UV–Vis. Spectrophotometer (200–800 nm); The FT-IR spectra were recorded using a Shimadzu FT-IR 8400 in the range of 400–4,000 cm−1 (KBr disc); MIRA3TESCAN-XMU was used to report the FE-SEM Images and EDS result. The XRD pattern of CoNPs was recorded in the 2θ range of 20°–80° by a GNR EXPLORER instrument at a voltage of 40 kV, a current of 30 mA, and Cu-Kα radiation (1.5406 Å). The average crystal size of CoNPs was calculated using X‐ray diffraction according to the Debye–Scherrer equation

Analysis of cytotoxicity of CoNPs

Human umbilical vein endothelial cells (HUVECs) was used to investigate the efficacy of silver nanoparticles in the culture medium. To this end, the cell line was placed in T25 flasks along with complete culture medium, including DMEM (Dulbecco's Modified Eagle Medium), 10% decamplmaneh fetal bovine serum, and 1% penicillin–streptomycin solution and incubated at 37 °C along with 5% CO2. After cell density reached 80%, the sample was exposed to 1% of EDTA-trypsin solution. After 3 min incubation at 37 °C along with 5% CO2 in the cell culture incubator and observing the cells detached from the plate floor, the sample was centrifuged for 5 min at 5,000 rpm and the cell deposition was trypsinized by adding the culture medium. Then, the cell suspensions were counted by Neobar slide after trypan blue staining, and cell toxicity test was done by MTT assay. For this reason, 10,000 HUVEC cells along with 200 µL complete culture medium were added to each 98-plate culture plate. To achieve cells with single layer density, the plate was incubated again at 37 °C along with 5% CO2. After 80% of cell growth was achieved, the culture medium was removed and the surface of the cells was irrigated with FBS, and 100 µL double concentration culture medium was added afterward. Then, 100 µL Co(NO3)2, Z. clinopodioides, and CoNPs solution soluble in PBS were added to the well 1 (1000 µg/mL). After mixing Co(NO3)2, Z. clinopodioides, and CoNPs in the culture medium, 100 µL of the first well was removed and added to the second well. Next, 100 µL of the second well was removed and added to well 3. This process was continued up to well 11 so that half of the Co(NO3)2, Z. clinopodioides, and CoNPs were added to each well. Well 12 only contained the cell and single concentration complete culture medium and remained as control. The plate was incubated at 37 °C for 24 h at the presence of 5% CO2, after which cell toxicity was determined by tetrazolium staining. After that, 10 µL of tetrazolium stain (5 mg/mL) was added to the wells, including the control, and the plate was incubated at 37 °C for 2 h at the presence of 5% CO2. Then, the stain was removed from the wells and 100 µL of DMSO was added to the wells. The plate was wrapped in an aluminum foil and shaken for 20 min in a shaker. Finally, cell viability was recorded by an ELISA reader at a wavelength of 570 nm according to the following formula[38]:

Measurement of antioxidant properties of CoNPs by DPPH

To determine the trapping potential of DPPH, different concentrations of the Co(NO3)2, Z. clinopodioides, and CoNPs were mixed with 2 mL 0.004% DPPH solution. The control solution contained 2 mL DPPH and 2 mL ethanol. The solutions were kept in darkness at room temperature for 30 min. Then, the absorption rate of the samples was measured at 517 nm by the following formula compared to the control sample[39]:

Preparation of fungal and bacterial species

Salmonella typhimurium (ATCC No. 14028) and Streptococcus pneumonia (ATCC No. 49619) were procured as lyophilized from Iranian Research Organization for Science and Technology. Also, four fungal species, namely Candida albicans (PFCC No. 89-1000), Candida glabrata (PFCC No. 164-665), Candida krusei (PFCC No. 52951), Candida guilliermondii (PFCC No. 88-1947), and four bacterial species, namely Pseudomonas aeruginosa (ATCC No. 27853), Escherichia coli O157:H7 (ATCC No. 25922), Bacillus subtilis (ATCC No. 6633), and Staphylococcus aureus (ATCC No. 25923) were procured as lyophilized from Pasteur Institute of Iran.

Analysis of sensitivity of fungal and bacterial strains to CoNPs

Agar disk-diffusion and well-diffusion methods were used to analyze the antifungal and antibacterial activities. To this end, the prepared microbial suspension with 0.5 McFarland turbidity standard was cultured onto Mueller Hinton Agar and Sabouraud Dextrose Agar in completely sterile conditions. In the well diffusion method, 6-mm wells were created by a Pasteur pipette on the culture medium with constant distances. In the disk diffusion method, 6-mm blank disks were used on agar culture medium. Then, 60 µL of different dilutions of Co(NO3)2, Z. clinopodioides, and CoNPs were added to the wells and disks. In this study, distilled water was negative control and antifungal [Fluconazole (60 mg/mL), Itraconazole (60), Miconazole (60), Amphotericin B (60), Nystatin (60)] and antibacterial [Difloxacin (30 mg/mL), Chloramphenicol (30), Streptomycin (10), Gentamicin (10), Oxytetracycline (30), Ampicillin (10), and Amikacin (25)] antibiotics were positive controls. The zone of growth inhibition was recorded after 24 h of incubation at 37 °C[40].

Macro broth dilution method was used to determine Minimum Inhibitory Concentration (MIC). Different dilutions of Co(NO3)2, Z. clinopodioides, and CoNPs were added to macro broth tubes, following which 60 µL fungal and bacterial suspensions were added and incubated for 24 h at 37 °C. Then, the concentration with minimum dilution and no turbidity was considered MIC[40].

To determine minimum bacterial concentration (MBC) and minimum fungicidal concentration (MFC), 60 µL MIC and three preceding chambers were cultured on Muller Hinton Agar and Sabouraud Dextrose Agar, respectively. After 24 h incubation at 37 °C, the minimum concentration with no fungal and bacterial growth was considered MBC and MFC, respectively. All tests were done in triplet[40].

In vivo design

All animal procedures were approved by standards of Kermanshah Payame Noor University (No. 01/Z/G 1395/12/01) on Humane Care and Use of Laboratory Animals, in accordance with the Research Ethics Committee of the Ministry of Health and Medical Education in Iran (adopted on April 17, 2006), based on the Helsinki Protocol (Helsinki, Finland, 1975). A total of 60 male rats of the same race with the weight of 220 ± 5 g were used in this study. The rats were kept in individual cages at 22 ± 2 °C, in 12:12 h dark–light cycle, and with free access to water and food. The rats were anesthetized by intramuscular administration of 40 mg/kg ketamine. After induction of anesthesia, the hair between the two scapulae was shaven, and 3 × 3 cm of the area was disinfected with 70% ethanol. A wound (2 × 2 cm) was made by a scalpel, which involved the removal of all cutaneous layers. The depth of the wound included dermis and hypodermis (Fig. 2).

Figure 2

Excision model in rat (S show wound area).

After creating the cutaneous wound, the rats were randomly divided into six groups: untreated control, treatment with Eucerin basal ointment, treatment with 3% tetracycline ointment, treatment with 0.2% Co(NO3)2 ointment, treatment with 0.2% Z. clinopodioides ointment, and treatment with 0.2% CoNPs ointment. The ointment was applied to the wound bed for 10 consequent days.

On day 10 after complete anesthesia by inhalation of chloroform in a desiccator, a sample was taken from the wound in each group. Histological sections were equally divided into half, half of which was sent to the laboratory in 10% formalin. After staining the samples by hematoxylin–eosin staining technique, they were analyzed by an optic microscope. In the histopathological study, the number of total cells, blood vessel, fibrocyte, fibroblast, neutrophil, lymphocyte, and macrophage and ratio of fibrocyte to fibroblast were measured. Biochemical studies by determining of hydroxyl proline, hexosamine, and hexuronic acid concentrations were performed on another half of the samples[34].

Enzyme studies

As previously revealed, the inhibition effect of new nanoparticles (CoNPs) on pain and BChE activities was specified according to Ellman's spectrophotometric method[34]. The α-glycosidase inhibition effect of the new nanoparticles (CoNPs) was adjusted similar to the work of TAO et al.[34]. As mentioned earlier, the absorption values were determined at 405 nm[34].

Statistical analysis

The obtained results were fed into SPSS-22 software and analyzed by one-way ANOVA, followed by Duncan post-hoc test (P ≤ 0.01).

Results and discussion

Cobalt nanoparticles are used as a therapeutic tool for the treatment of various disease such as microbial infections[41-43]. Therefore, the properties of nanoparticles and their effect on microbes are of great significance in medical applications[41]. Most bacteria have become resistant to antibiotics. Hence, it will be urgent to replace antibiotics with new materials that have antibacterial properties[42,43]. Since low-concentrated cobalt nanoparticles are non-toxic in the body, they are a good substitute for antibiotics[41,43]. These materials in lower concentrations prevent bacterial ad fungal growth and have fewer side effects than antibiotics. There are numerous reports about the use of biological synthesis of cobalt nanoparticles and their antimicrobial activity[41-43]. The present study evaluated the efficacy of CoNPs in the destroying of bacterial and fungal pathogens and healing of cutaneous wound without any cytotoxicity.

Chemical characterization of CoNPs

UV–visible spectroscopy analysis

The UV–Vis. spectra of biosynthesized CoNPs using aqueous extract of Ziziphora is shown in Fig. 3. The surface plasmon resonance of CoNPs was confirmed by UV–Vis. with observed peaks at 222, 295, and 449 nm which are reported previously[36].

Figure 3

UV–Vis spectra of biosynthesized CoNPs using Ziziphora extract.

FT‐IR analysis

FT‐IR spectroscopy is a common technique to identify functional groups of diverse organic compounds based on the peak value in the region of 400–4,000 cm−1. This spectroscopic method is also a sufficient way to recognize the bioactive components in the natural products field. According to the results, a similarity has been observed for FT-IR spectrums of the Z. clinopodioides extract and CoNPs (Fig. 4), that could be approved the biosynthesis of the cobalt nanoparticles. The presences of different IR bands related to existences of various functional groups in Ziziphora extract. For instance, peaks in 3,377 and 2,933 cm−1 related to O–H and aliphatic C–H stretching; the peaks at a range of 1,417 to 1,733 cm−1 correspond to C=C and C=O stretching, and peaks at 1,256 and 1,068 cm−1 could be ascribed to –C–O and –C–O–C stretching. These peaks could be considered for the presence of various compounds such as phenolic, flavonoid, and carboxylic compounds which have been reported previously[31,44].

Figure 4

FT-IR spectra of Ziziphora extract, and CoNPs.

XRD analysis

The crystallinity of CoNPs was evaluated from the XRD patterns. The diffractogram is shown in Fig. 5. exposes despite the small size of cobalt nanoparticles, they are well crystallized. The attained data were compared with the standard database ICDD PDF card no. 00-015-0806. The peaks at 44.32, 51.38, and 76.15 corresponding to CoNPs (111), (200), and (220) diffraction planes, indicate the formation of CoNPs. The size of the crystals is calculated using Scherrer's formula. It is calculated that the cobalt nanoparticles have an average crystal size of 28.19 nm.

Figure 5

XRD pattern of CoNPs.

SEM analysis

Field emission scanning electron microscope (FE-SEM) was used to recognize surface morphology and size of CoNPs indicated the formation of homogeneous cobalt NPs with an average diameter size of 29.07 nm. Figure 6a–d show the SEM images of CoNPs in different scales. As it is seen, the nanoparticles are aggregated and make particles with large size. The aggregation of the nanoparticles is a well-known occurrence in biosynthesis methods of metallic nanoparticles, as it has been reported previously[45,46].

Figure 6

SEM images of CoNPs.

TEM analysis

TEM micrograph showed the surface morphology of synthesized nanoparticles (Fig. 7). The particle size distribution in the TEM image shows that the majority of nanoparticles were less than 30 nm. The particles were also found to be spherical. The SEM and TEM investigation gave similar results for the range of nanoparticles size. According our study, a few studies reported the biosynthesize of CoNPs using plants extracts. The range size of cobalt ferrites nanoparticles synthesized using aqueous extracts of sesame was 3–20.45 nm[47]. CoNPs was also biosynthesized using methanolic extracts of Conocarpus erectus and Nerium indicum. The size of particles was estimated in the range of 20–60 nm[37]. The average particle size of CoNPs, which was produced using aqueous extracts of Raphanus sativus, was reported 80 nm[36]. The particle size ranging from 20 to 50 nm was reported for of cobalt nanoparticles that were biosynthesized using Moringa oleifera extract[48].

Figure 7

TEM images of CoNPs.

EDS analysis

The EDS analysis of CoNPs is shown in Fig. 8. The result demonstrates the clear elemental composition profile of the biosynthesized CoNPs. The presences of cobalt in synthesized NPs was by the observed peaks including CoLα below of 1Kev; CoKα around 7Kev; and CoKβ below 8.

Figure 8

EDS analysis of CoNPs.

Antifungal and antibacterial effects of CoNPs

Analysis of results in this research (Tables 1, 2, 3, 4, 5, 6) revealed that almost all of the tested bacteria and fungi were sensitive to CoNPs and showed more antifungal and antibacterial activities than standard antibiotics. There was no significant difference in inhibitory zone of all bacteria between many dilutions of CoNPs and Difloxacin (30 mg/mL), Chloramphenicol (30), Streptomycin (10), Gentamicin (10), Oxytetracycline (30), Ampicillin (10), and Amikacin (25) and in inhibitory zone of all fungi between several concentrations of CoNPs and Fluconazole (60 mg/mL), Itraconazole (60), Miconazole (60), Amphotericin B (60), Nystatin (60). There was an increase in the inhibition zone in many of the samples when CoNPs increased. The findings showed a noticeable difference regarding sensitivity to CoNPs in the bacteria and fungi tested. The widest inhibition zone in agar well and disk diffusion test was seen at 64 mg/mL concentration. In agar well diffusion, no inhibitory effect of CoNPs was observed at 1 mg/mL concentration in the case of E. coli and S. typhimurium (p ≤ 0.01). CoNPs prevented B. subtilis, S. pneumonia/S. aureus/P. aeruginosa/C. glabrata/C. guilliermondii/C. krusei, and E. coli/S. typhimurium/C. albicans growth at 1, 2, and 4 mg/mL concentrations, respectively and destroyed B. subtilis/S. pneumonia/S. aureus/P. aeruginosa/C. krusei, E. coli/C. guilliermondii/C. glabrata/C. albicans, and S. typhimurium at 2, 4, and 8 mg/mL concentrations, respectively. Thus, the findings showed strong antifungal and antibacterial properties of CoNPs against all of the tested fungi and bacteria. Moreover, CoNPs had the highest antibacterial and antifungal effects on B. subtilis and C. krusei, respectively (p ≤ 0.01). In agreement with our experiment, in study of Hemmati et al.[5] showed that metal nanoparticles had strong antibacterial activities against Gram-negative bacteria include Proteus mirabilis (ATCC No. 25933), Shigella flexneri (ATCC No. 12022), Listeria monocytogenes (ATCC No. 13932), Klebsiella pneumonia (ATCC No. 9997), Pseudomonas aeruginosa (ATCC No. 27853), Escherichia coli O157:H7 (ATCC No. 25922), and Salmonella typhimurium (ATCC No. 14028) and Gram-positive bacteria include Enterococcus faecalis (ATCC No. 29212), Bacillus subtilis (ATCC No. 6633), Streptococcus pyogenes (ATCC No. 10403), Staphylococcus saprophyticus (ATCC No. 49453), Staphylococcus epidermidis (ATCC No. 12228), Staphylococcus aureus (ATCC No. 25923), and Streptococcus pneumonia (ATCC No. 49619)[5].

Table 1

The growth inhibition zones of fungi in agar disk diffusion assay in various concentrations of CoNPs, Z. clinopodioides, and Co(NO3)2.

Dilution (mg/mL)	Inhibition zone in disk diffusion (mm)
	C. albicans	C. glabrata	C. guilliermondii	C. krusei
Fluconazole (60)	39 ± 0.7a	42.4 ± 1.34a	45 ± 1a	44.2 ± 1.3a
Itraconazole (60)	35.6 ± 0.89ab	40.4 ± 0.89a	43.4 ± 0.89a	41.4 ± 0.54a
Miconazole (60)	41.6 ± 0.89a	45.2 ± 1.3a	46.2 ± 1.3a	40.4 ± 1.34a
Amphotericin B (60)	36.4 ± 0.89ab	41.4 ± 1.34a	40.2 ± 0.83a	38.6 ± 0.89a
Nystatin (60)	31.2 ± 1.3ab	37.2 ± 1.3ab	40.8 ± 0.44a	35.4 ± 0.89ab
CoNPs (64)	41.4 ± 1.34a	43.2 ± 0.83a	44.6 ± 0.89a	44.2 ± 1.3a
CoNPs (32)	35.4 ± 1.34ab	40.2 ± 1.3a	39.2 ± 0.83a	40.6 ± 1.14a
CoNPs (16)	31.6 ± 0.89ab	33.8 ± 1.09ab	35.4 ± 0.54ab	35.2 ± 0.83ab
CoNPs (8)	24.2 ± 1.3b	28.6 ± 0.89b	31.4 ± 1.34ab	32.2 ± 1.3ab
CoNPs (4)	21.2 ± 0.44bc	23.4 ± 0.89b	25.2 ± 1.3b	28.8 ± 0.44b
CoNPs (2)	16.6 ± 0.89bc	19.2 ± 1.3bc	21.2 ± 0.44bc	22.6 ± 0.89bc
CoNPs (1)	13.2 ± 0.83c	17.6 ± 1.14bc	18.2 ± 0.83bc	16.2 ± 0.44bc
Z. clinopodioides (64)	32 ± 1.22ab	35.2 ± 1.3ab	34 ± 1.22ab	35.2 ± 1.3ab
Z. clinopodioides (32)	30.4 ± 0.89ab	31.4 ± 1.34ab	29.4 ± 1.34b	31.4 ± 1.34ab
Z. clinopodioides (16)	24.4 ± 1.34b	25.2 ± 0.44b	24 ± 0.7b	25 ± 0.7b
Z. clinopodioides (8)	21 ± 1bc	21.2 ± 1.3bc	21.6 ± 0.89bc	22.4 ± 1.34bc
Z. clinopodioides (4)	15.2 ± 1.3bc	20.2 ± 0.83bc	19.4 ± 0.89bc	17.4 ± 1.34bc
Z. clinopodioides (2)	12.2 ± 0.83c	16.2 ± 0.83bc	16.8 ± 0.44bc	17.6 ± 0.89bc
Z. clinopodioides (1)	11.4 ± 1.34c	11.6 ± 0.89c	13.2 ± 1.3c	14 ± 1.22c
Co(NO3)2 (64)	25.6 ± 0.89b	28.6 ± 0.89b	29.2 ± 0.83b	29.6 ± 0.89b
Co(NO3)2 (32)	24.8 ± 0.44b	22 ± 1.22bc	24.4 ± 0.54b	24.8 ± 1.09b
Co(NO3)2 (16)	21.2 ± 1.3bc	18.4 ± 0.89bc	21.2 ± 1.3bc	19.6 ± 0.89bc
Co(NO3)2 (8)	15.4 ± 0.54bc	16 ± 0.7bc	16.6 ± 1.14bc	16.6 ± 1.14bc
Co(NO3)2 (4)	10.4 ± 1.34c	13.8 ± 0.44c	12 ± 1c	14.2 ± 1.3c
Co(NO3)2 (2)	9 ± 0c	12.4 ± 0.89c	11.6 ± 1.14c	11 ± 0c
Co(NO3)2 (1)	0 ± 0d	0 ± 0d	0 ± 0d	8 ± 0c
Distilled water	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.01).

Table 2

The growth inhibition zones of fungi in agar well diffusion assay in various concentrations of CoNPs, Z. clinopodioides, and Co(NO3)2.

Dilution (mg/mL)	Inhibition zone in well diffusion (mm)
	C. albicans	C. glabrate	C. guilliermondii	C. krusei
CoNPs (64)	30.6 ± 0.89a	34.6 ± 1.14a	34.2 ± 0.44a	35.4 ± 0.54a
CoNPs (32)	25 ± 1ab	31.2 ± 0.83a	31.2 ± 1.3a	32.8 ± 0.44a
CoNPs (16)	19.4 ± 0.89bc	27.2 ± 1.3ab	25.4 ± 0.54ab	26.2 ± 1.3ab
CoNPs (8)	14.2 ± 1.3c	25.2 ± 1.3ab	21 ± 1.22b	23.4 ± 1.34b
CoNPs (4)	11.4 ± 0.54c	21.4 ± 1.34b	20.6 ± 0.89b	20.2 ± 1.3b
CoNPs (2)	8.2 ± 1.3c	15.4 ± 0.89bc	15.8 ± 1.09bc	17.2 ± 0.83bc
CoNPs (1)	8.2 ± 0.44c	11.6 ± 0.89c	12.8 ± 0.44c	13.4 ± 0.89c
Z. clinopodioides (64)	19.8 ± 0.44bc	21.6 ± 0.89b	23.2 ± 1.3b	25.6 ± 1.14ab
Z. clinopodioides (32)	15.6 ± 0.89bc	17.4 ± 1.34bc	20 ± 0b	22.2 ± 1.3b
Z. clinopodioides (16)	13.6 ± 1.14c	14.6 ± 1.14c	14.2 ± 0.44c	21.4 ± 1.34b
Z. clinopodioides (8)	11.4 ± 1.34c	12.4 ± 0.89c	13 ± 1c	14.6 ± 0.89c
Z. clinopodioides (4)	9.4 ± 1.34c	9.6 ± 0.89c	11.2 ± 1.3c	12.4 ± 0.54c
Z. clinopodioides (2)	0 ± 0d	9.4 ± 0.54c	10 ± 1.22c	11.6 ± 0.89c
Z. clinopodioides (1)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d
Co(NO3)2 (64)	13.2 ± 0.83c	16.8 ± 1.09bc	18 ± 1bc	19 ± 0.7bc
Co(NO3)2 (32)	11.6 ± 0.89c	14.8 ± 0.44c	13.6 ± 0.89c	15 ± 1.22bc
Co(NO3)2 (16)	9.8 ± 0.44c	12.4 ± 1.34c	12.4 ± 1.34c	13.8 ± 1.09c
Co(NO3)2 (8)	9.4 ± 0.89c	11.2 ± 1.3c	12.6 ± 0.89c	11.2 ± 1.3c
Co(NO3)2 (4)	0 ± 0d	10.6 ± 0.89c	9.8 ± 0.44c	10 ± 0c
Co(NO3)2 (2)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d
Co(NO3)2 (1)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d
Distilled water	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.01).

Table 3

MIC and MFC of CoNPs, Z. clinopodioides, and Co(NO3)2 against fungi.

Dilution (mg/mL)	C. albicans	C. glabrata	C. guilliermondii	C. krusei
MICCoNPs	4 ± 0b	2 ± 0a	2 ± 0a	2 ± 0a
MICZ. clinopodioides	8 ± 0c	4 ± 0b	4 ± 0b	4 ± 0b
MICCo(NO3)2	8 ± 0c	8 ± 0c	4 ± 0c	2 ± 0c
MFCCoNPs	4 ± 0B	4 ± 0B	4 ± 0B	2 ± 0A
MFCZ. clinopodioides	8 ± 0C	8 ± 0C	8 ± 0C	4 ± 0C
MFCCo(NO3)2	16 ± 0D	8 ± 0D	8 ± 0D	8 ± 0D

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.01).

Table 4

The growth inhibition zones of bacteria in agar disk diffusion assay in various concentrations of CoNPs, Z. clinopodioides, and Co(NO3)2.

Dilution (mg/mL)	Inhibition zone in disk diffusion (mm)
	Gram-positive bacteria			Gram-negative bacteria
	S. typhimurium	E. coli	P. aeruginosa	S. aureus	S. pneumoniae	B. subtilis
Difloxacin (30)	27 ± 0.7b	29.2 ± 0.44b	33.8 ± 1.09ab	27.2 ± 1.3b	24.2 ± 0.44b	30.6 ± 0.89ab
Chloramphenicol (30)	25.6 ± 0.89b	22.4 ± 0.54bc	23.6 ± 1.14b	23.4 ± 0.89b	24.2 ± 0.83b	27 ± 0.7b
Streptomycin (10)	17.2 ± 1.3bc	20.2 ± 0.83bc	17.2 ± 1.3bc	17.6 ± 0.89bc	18.2 ± 1.3bc	28.2 ± 1.3b
Gentamicin (10)	20.4 ± 1.34bc	25.4 ± 1.34b	20.8 ± 1.09bc	20 ± 1.22bc	22.4 ± 0.89bc	21 ± 1bc
Oxytetracycline (30)	26.4 ± 0.54b	24 ± 1b	20.2 ± 1.3bc	24.6 ± 0.89b	23.2 ± 1.3b	24.4 ± 0.54b
Ampicillin (10)	19.2 ± 1.3bc	24.4 ± 1.34b	19.2 ± 1.3bc	24 ± 0.7b	20.8 ± 0.44bc	18.8 ± 1.09bc
Amikacin (25)	28.2 ± 0.83b	24.2 ± 1.3b	21.6 ± 1.14bc	25.6 ± 0.89b	27.6 ± 1.14b	25.4 ± 0.89b
CoNPs (64)	40.6 ± 1.14a	41.8 ± 0.44a	45.2 ± 0.44a	44.2 ± 0.44a	46.2 ± 1.3a	47 ± 1a
CoNPs (32)	33.4 ± 1.34ab	36.4 ± 0.89ab	38.6 ± 0.89a	38.2 ± 1.3a	40.4 ± 0.54a	42.4 ± 1.34a
CoNPs (16)	28 ± 1.22b	34.4 ± 1.34ab	32.2 ± 0.83ab	34.4 ± 1.34ab	35.2 ± 1.3ab	34 ± 1.22ab
CoNPs (8)	24 ± 1.22b	26.2 ± 1.3b	30.2 ± 1.3ab	30 ± 1.22ab	33 ± 0.7ab	29.4 ± 0.89b
CoNPs (4)	21.4 ± 0.54bc	21 ± 0.7bc	25 ± 1.22b	24 ± 1b	26.6 ± 0.89b	23.2 ± 1.3b
CoNPs (2)	15.2 ± 1.3bc	14.4 ± 0.89c	21.4 ± 0.89bc	20.4 ± 0.89bc	21 ± 0.7bc	20 ± 0.7bc
CoNPs (1)	11.6 ± 1.14c	11.4 ± 1.34c	14.2 ± 0.83c	15.4 ± 0.89bc	17.4 ± 0.54bc	17.6 ± 0.89bc
Z. clinopodioides (64)	28 ± 1.22b	29.6 ± 0.89b	32.4 ± 1.34ab	33.2 ± 0.44ab	35 ± 0.7ab	35 ± 0.7ab
Z. clinopodioides (32)	24.2 ± 0.83b	24.2 ± 1.3b	26.4 ± 0.54b	28.8 ± 0.44b	33.6 ± 1.14ab	31.4 ± 1.34ab
Z. clinopodioides (16)	21.4 ± 1.34bc	22.2 ± 0.83bc	23 ± 0.7b	24.6 ± 0.89b	27.2 ± 1.3b	27 ± 0.7b
Z. clinopodioides (8)	15 ± 1bc	17.8 ± 0.44bc	21.8 ± 0.44bc	21.4 ± 1.34bc	24.4 ± 0.89b	21.4 ± 0.54bc
Z. clinopodioides (4)	11.2 ± 1.3c	12.6 ± 1.14c	14 ± 0c	15.4 ± 0.54bc	18.4 ± 0.54bc	17.2 ± 1.3bc
Z. clinopodioides (2)	9.2 ± 0.83c	10.6 ± 0.89c	10.4 ± 1.34c	12.2 ± 1.3c	12 ± 1.22c	14.8 ± 1.09c
Z. clinopodioides (1)	0 ± 0d	0 ± 0d	8.8 ± 1.09c	8.8 ± 0.44c	10.6 ± 0.89c	11.8 ± 0.44c
Co(NO3)2 (64)	22 ± 1.22bc	24.8 ± 0.44b	25.2 ± 0.44b	25 ± 1b	27.6 ± 0.89b	27.4 ± 1.34b
Co(NO3)2 (32)	15.8 ± 1.09bc	20 ± 0.7bc	20 ± 0.7bc	20.8 ± 0.44bc	23.8 ± 1.09b	23 ± 1.22b
Co(NO3)2 (16)	12.2 ± 1.3c	15.4 ± 1.34bc	16.6 ± 0.89bc	18 ± 0.7bc	19.2 ± 1.3bc	19.4 ± 1.34bc
Co(NO3)2 (8)	9.4 ± 1.34c	13 ± 1c	13 ± 1.22c	14.4 ± 1.34c	15 ± 0.7bc	16.4 ± 0.54bc
Co(NO3)2 (4)	8.4 ± 1.34c	9.4 ± 0.89c	10 ± 0c	11.4 ± 0.54c	11.6 ± 0.89c	13 ± 0c
Co(NO3)2 (2)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	8.8 ± 0.44c	10.2 ± 1.3c
Co(NO3)2 (1)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d
Distilled water	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.01).

Table 5

The growth inhibition zones of bacteria in agar well diffusion assay in various concentrations of CoNPs, Z. clinopodioides, and Co(NO3)2.

Dilution (mg/mL)	Inhibition zone in well diffusion (mm)
	Gram-positive bacteria			Gram-negative bacteria
	S. typhimurium	E. coli	P. aeruginosa	S. aureus	S. pneumoniae	B. subtilis
CoNPs (64)	33.6 ± 1.14ab	36.2 ± 0.83a	38.4 ± 0.54a	38.2 ± 0.44a	39 ± 1a	40.2 ± 1.3a
CoNPs (32)	31.4 ± 0.89ab	31.2 ± 0.44ab	31.4 ± 0.89ab	31 ± 1ab	34.6 ± 0.89ab	33.8 ± 0.44ab
CoNPs (16)	24.2 ± 1.3b	26.2 ± 0.83b	26.2 ± 1.3b	27.4 ± 0.89b	25.6 ± 1.14b	29.4 ± 0.54b
CoNPs (8)	20.6 ± 0.89bc	22.4 ± 1.34bc	21.4 ± 1.34bc	24.4 ± 0.89b	22.6 ± 0.89bc	27.4 ± 0.89b
CoNPs (4)	13.4 ± 1.34c	15.6 ± 0.89bc	17.2 ± 1.3bc	18 ± 1.22bc	18.4 ± 0.54bc	21.2 ± 1.3bc
CoNPs (2)	8.2 ± 0.44c	10.4 ± 0.54c	12 ± 0c	14.2 ± 0.44c	13.2 ± 1.3c	15.4 ± 0.89bc
CoNPs (1)	0 ± 0d	0 ± 0d	8.4 ± 1.34c	9.8 ± 0.44c	10.4 ± 0.54c	12.2 ± 0.83c
Z. clinopodioides (64)	24.8 ± 0.44b	25.4 ± 0.89b	27 ± 1b	28.8 ± 0.44b	28.4 ± 0.89b	30.8 ± 1.09ab
Z. clinopodioides (32)	19.6 ± 1.14bc	21.2 ± 1.3bc	23.8 ± 0.44b	24 ± 0.7b	22.8 ± 0.44bc	27.2 ± 0.44b
Z. clinopodioides (16)	13.2 ± 0.83c	19 ± 1.22bc	20.8 ± 1.09bc	19.2 ± 0.83bc	20.4 ± 0.54bc	22.4 ± 1.34bc
Z. clinopodioides (8)	11.8 ± 1.09c	13 ± 1c	15.8 ± 1.09bc	14 ± 1.22c	17 ± 1bc	16 ± 1.22bc
Z. clinopodioides (4)	8.2 ± 0.83c	9.2 ± 1.3c	10.4 ± 1.34c	12 ± 0.7c	13.6 ± 1.14c	15.4 ± 1.34bc
Z. clinopodioides (2)	0 ± 0d	8.2 ± 0.44c	10.6 ± 1.14c	9.6 ± 0.89c	10 ± 0.7c	12 ± 1.22c
Z. clinopodioides (1)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	10 ± 0c
Co(NO3)2 (64)	14.4 ± 0.54c	16.4 ± 0.89bc	18 ± 0.7bc	17 ± 1.22bc	18 ± 0.7bc	20.6 ± 0.89bc
Co(NO3)2 (32)	10.2 ± 1.3c	11.6 ± 1.14c	13 ± 0.7c	13 ± 0c	14.8 ± 0.44c	17.8 ± 0.44bc
Co(NO3)2 (16)	8.6 ± 0.89c	9.2 ± 0.83c	11.2 ± 1.3c	12.4 ± 1.34c	12.4 ± 0.54c	13.2 ± 1.3c
Co(NO3)2 (8)	0 ± 0d	8 ± 0c	10 ± 0c	10.4 ± 0.89c	11 ± 0.7c	11 ± 0.7c
Co(NO3)2 (4)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	8.4 ± 0.54c	9.8 ± 0.44c
Co(NO3)2 (2)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d
Co(NO3)2 (1)	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d
Distilled water	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d	0 ± 0d

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.01).

Table 6

MIC and MBC of CoNPs, Z. clinopodioides, and Co(NO3)2 against bacteria.

Dilution (mg/mL)	Gram-negative bacteria			Gram-positive bacteria
	S. typhimurium	E. coli	P. aeruginosa	S. aureus	S. pneumoniae	B. subtilis
MICCoNPs	4 ± 0c	4 ± 0c	2 ± 0b	2 ± 0b	2 ± 0b	1 ± 0a
MICZ. clinopodioides	8 ± 0d	8 ± 0d	8 ± 0d	8 ± 0d	4 ± 0c	2 ± 0b
MICCo(NO3)2	16 ± 0e	8 ± 0d	8 ± 0d	8 ± 0d	4 ± 0c	4 ± 0c
MBCCoNPs	8 ± 0C	4 ± 0B	2 ± 0A	2 ± 0A	2 ± 0A	2 ± 0A
MBCZ. clinopodioides	16 ± 0D	16 ± 0D	8 ± 0C	8 ± 0C	4 ± 0B	4 ± 0B
MBCCo(NO3)2	32 ± 0E	32 ± 0E	8 ± 0C	16 ± 0D	8 ± 0C	8 ± 0C

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.01).

Cutaneous wound healing potential of CoNPs

In the recent experiment, the findings of wound area and contractures, total cell, and blood vessel revealed that CoNPs ointment significantly (p ≤ 0.01) amended the above parameters at day 10 compared to the other groups (Tables 7, 8; Figs. 9,10). Angiogenesis is defined as the formation of new capillaries from previous vessels. Angiogenesis is a controlled process that is rarely seen in adults except in instances of wound healing and menstrual cycle in women[49]. It is also a phenomenon that mostly occurs in the impaired areas, which is aimed at secreting cytokines in the vessels to repair tissues. Angiogenesis is higher in the early days, reaching its maximum level from days 10 to 15. This level is then reduced with complete withdrawal of cytokines and other tissue repair factors[50].

Table 7

The level of macroscopic parameters in experimental groups.

Parameters	Groups (n = 10)
	Control	Basal ointment	Tetracycline ointment	Co(NO3)2 ointment	Z. clinopodioides ointment	CoNPs ointment
Wound area (cm2)	2.6 ± 0.2c	2.6 ± 0.2c	1.9 ± 0.1b	2 ± 0b	1.8 ± 0.3b	1.2 ± 0.1a
Wound contractures (%)	35 ± 4c	35 ± 4c	52.5 ± 2b	50 ± 0b	55 ± 6b	70 ± 2a

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.05).

Table 8

The level of microscopic parameters in experimental groups.

Parameters	Groups (n = 10)
	Control	Basal ointment	Tetracycline ointment	Co(NO3)2 ointment	Z. clinopodioides ointment	CoNPs ointment
Total cell (n)	1,398.9 ± 32.8c	1,376.2 ± 24.3c	1,210.1 ± 32.1b	1,254.6 ± 25.4b	1,232.9 ± 19.6b	984.3 ± 32.1a
Vessel (n)	3.8 ± 0.2c	4.2 ± 0.4c	7.9 ± 0.7b	7.1 ± 0.5b	7.9 ± 0.5b	12.5 ± 0.4a
Fibrocyte (n)	2.1 ± 0.1c	2.5 ± 0.3c	6.1 ± 0.4b	5.4 ± 0.3b	9.9 ± 0.4a	11 ± 0.5a
Fibroblast (n)	13.2 ± 0.8d	14.3 ± 1.2d	18.8 ± 0.7c	23.3 ± 0.5b	23.9 ± 0.2b	27.9 ± 1.1a
Fibrocyte to fibroblast (ratio)	0.15 ± 0.02d	0.17 ± 0.01d	0.32 ± 0.02b	0.23 ± 0.02c	0.41 ± 0.03a	0.39 ± 0.02a
Lymphocyte (n)	21.3 ± 0.9c	19.9 ± 0.7c	12.1 ± 0.5b	13.5 ± 0.8b	12.1 ± 0.7b	6.4 ± 0.6a
Macrophage (n)	4.8 ± 0.2a	4.6 ± 0.4a	5.1 ± 0.3a	5.2 ± 0.4a	4.5 ± 0.2a	4.8 ± 0.5a
Neutrophil (n)	32.5 ± 1.5d	29.8 ± 0.9d	15.6 ± 0.8b	22.1 ± 0.9c	14.2 ± 1.2b	4.5 ± 0.3a

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.05).

Figure 9

Macroscopic wound images of the control (A), basal ointment (B), tetracycline ointment (C), Co(NO3)2 ointment (D), Z. clinopodioides ointment (E), and CoNPs ointment (F) on 10 days post-injury. Scale bar: 4 mm.

Figure 10

Longitudinal section of wounds of the control (A), basal ointment (B), tetracycline ointment (C), Co(NO3)2 ointment (D), Z. clinopodioides ointment (E), and CoNPs ointment (F) on 10 days post-injury. Scale bar: 150 μm. Magnification × 200.

In our study, CoNPs ointment increased significantly (p ≤ 0.01) the number of fibrocyte, the concentration of hydroxyproline, hexuronic acid, and hexosamine and fibrocyte/fibroblast ratio at day 10 compared to the other groups (Tables 8, 9; Fig. 11). Fibroblasts are removed through the blood vessels formed at the wound site and are developed into fibrocytes after some time. The amount of fibroblast is usually high until day ten. The main role of fibroblasts is making collagen. In fact, fibroblasts synthesize collagen, repair the external matrix, and facilitate the wound contraction process[51]. One of the methods of wound healing facilitation is the use of fibroblast growth stimulant. It has been found that increasing the number of fibroblasts in the artificial skin leads to wound healing in in-vitro conditions[52]. Fibroblasts synthesize some components of the primary extracellular matrix of the wound bed such as fibronectin, hexosamine, and hexuronic acid, which provides a favorable ground for cell migration and proliferation. Fibroblasts then synthesize collagen, which provides tensile strength in the wound bed[53]. Fibrocytes are developed fibroblasts that have a higher ability in making collagen than fibroblasts. The more is the number of fibroblasts, the better is the wound healing[51]. Collagens are protein strains that are made of glycine, praline, and hydroxy proline amino acids. The amount of collagen is very low in the early days but abundantly found in the final days due to the increased number of fibroblasts. The tensile strength of wound is dependent not only on the content of tissue collagen but also on the organization and arrangement of collagen fibers and maturity of fibers[53].

Table 9

The level of biochemical parameters in experimental groups.

Parameters	Groups (n = 10)
	Control	Basal ointment	Tetracycline ointment	Co(NO3)2 ointment	Z. clinopodioides ointment	CoNPs ointment
Hydroxyproline (mg/g of tissue)	12.4 ± 0.7d	14.2 ± 0.9d	25.1 ± 0.5b	19.7 ± 1.1c	27.5 ± 0.9b	36.2 ± 0.9a
Hexosamine (mg/100 mg of tissue)	0.21 ± 0.05c	0.2 ± 0.04c	0.31 ± 0.04b	0.28 ± 0.01b	0.32 ± 0.05b	0.42 ± 0.05a
Hexuronic acid (mg/100 mg of tissue)	0.11 ± 0.03c	0.12 ± 0.03c	0.19 ± 0.02b	0.14 ± 0.02c	0.21 ± 0.03b	0.29 ± 0.04a

Non-identical letters reveal a notable shift between the experimental groups (p ≤ 0.05).

Figure 11

Longitudinal section of wounds of the control (A), basal ointment (B), tetracycline ointment (C), Co(NO3)2 ointment (D), Z. clinopodioides ointment (E), and CoNPs ointment (F) on 10 days post-injury. Scale bar: 600 μm. Magnification × 800.

The results of analysis of inflammatory cells (lymphocyte, macrophage, and neutrophil) indicated that CoNPs ointment regulated significantly (p ≤ 0.01) the number of these cells at day 10 compared to the other groups (Table 8). Lymphocytes, existing in the human peripheral blood mononuclear cells, are an important source of immunoregulatory cytokines in the blood circulation and inflammatory parts of the body. Lymphocytes are increased in the early days[54]. Macrophages are the most important cells in the inflammatory stage that contribute to the elimination of necrotic tissues and bacteria[55]. These cells also contribute to the localization of inflammation process and absorption of fibroblasts to initiate proliferation by releasing some chemotoxic factors. Therefore, any factor that absorbs or activates the macrophages may have a positive impact on the repair process. In the absence of macrophages, the number of fibroblasts migrating to the wound is also reduced[56]. Stimulation of receptors on the surface of cutaneous macrophages stimulates these cells to produce cytokines and advance some stages of wound healing[54,56]. Neutrophils prepare the wound area for tissue regeneration by cleaning the wound site from infections and microorganisms. These cells contribute to the acceleration of inflammatory response by releasing some chemotoxic factors to absorb other leucocytes[13]. Accumulation and overactivation of lymphocytes, macrophages, and neutrophils in the wound site and their extreme secretion produce pus in the infection site, which reduces the wound healing process and may lead to complete loss of the impaired tissue and even amputation. Further, the presence of free radicals in the wound site may increase the amount of pus[57,58].

Antioxidant activity of CoNPs

DPPH free radical scavenging effect of Z. clinopodioides and CoNPs in several concentrations (0, 1, 3, 7, 15, 31, 62, 125, 250, 500, and 1000 µg/mL) indicated impressive prevention similar to BHT. The IC50 of Z. clinopodioides, BHT, and CoNPs were 448, 342, and 342 µg/mL, respectively (Fig. 12). Agreement with our experiment, in the previous studies, indicated that metal nanoparticles had strong antioxidant properties, and they destroyed several free radicals such as DPPH[4,5].

Figure 12

Antioxidant potential of Co(NO3)2, Z. clinopodioides, BHT, and CoNPs. BHT butylated hydroxyl toluene.

Antioxidant compounds reduce the free radicals and pus in the wound area, thereby healing the wound completely[59,60]. Other papers have reported that the medicinal plants and their extraction rich in anti-inflammatory and antioxidant compounds significantly decrease the production of pus and enhance the wound healing process[59,60]. Our study indicated that CoNPs had a strong antioxidant activity. Therefore, it was normal to observe that CoNPs ointment had a notable wound healing activity.

Cytotoxicity survey of CoNPs

The cells treated with various concentrations of the present Co(NO3)2, Z. clinopodioides, and CoNPs were examined by MTT test for 48 h regarding cytotoxic effects on HUVEC cells. The absorbance rate was determined at 570 nm, which indicated extraordinary viability on HUVEC line even up to 1000 μg/mL for Co(NO3)2, Z. clinopodioides, and CoNPs (Fig. 13). The absence of any significant toxicity of CoNPs has numerous safe applications in pharmaceutical domains. Agreement with our experiment, in the study of Hamelian et al.[4] revealed when metal salts combine with biological compounds, their cytotoxicity removed[4].

Figure 13

Percent viability measured on human umbilical vein endothelial cells after treatment with present Co(NO3)2, Z. clinopodioides, and CoNPs.

Enzyme results

Cholinesterase enzymes inhibition results

All of novel nanoparticles (CoNPs) had remarkably higher AChE inhibitory effect than of control AChE inhibitor compound such as Tacrine. Indeed, the Ki values of novel nanoparticles and standard compound (tacrine) are summarized in Table 2. High inhibitory effect on ACHe (of these new nanoparticles), with Ki values of 0.42 ± 0.11 and 1.04 ± 0.24 mM. Later, all of these new nanoparticles obtained at the end of the experiment showed close inhibition profiles. The most active Co(NO3)2 showed Ki value of 0.42 ± 0.11 mM. The IC50 values of TAC as positive control for AChE and new nanoparticles were examined in the following order: Co(NO3)2 (0.68 mM, r2: 0.9654) < CoNPs (1.24 mM, r2: 0.9139) < TAC (1.98 mM, r2: 0.9883). The IC50 values of TAC as positive control for BChE and new nanoparticles are in the following order: Co(NO3)2 (1.32 mM, r2: 0.9768) < CoNPs (2.20 mM, r2: 0.9861) < TAC (3.84 mM, r2: 0.9812). In addition, new nanoparticles effectively inhibited BChE with values of 1.18 ± 0.17 and 1.91 ± 0.38 mM Ki, respectively. At the same time, all of these new nanoparticles synthesized had nearly close inhibition profiles. The most active Co(NO3)2 effectively inhibited BChE, with Ki value of 1.18 ± 0.17 mM. Indeed, recording novel inhibitors targeting AChE has still been of significant interest to the researchers. Additionally, it is recorded that selective BChE inhibitors can circumvent classical cholinergic toxicity. Hence, the development of novel selective BChE inhibitor compounds can provide additional benefits in the therapy of AD[61].

α-Glycosidase inhibition results

For enzyme glycosidase, new nanoparticles (CoNPs) have IC50 values of 15.86 and 11.26 µM and Ki values of 18.51 ± 2.73 and 15.70 ± 3.10 mM (Table 10). The results obtained clearly showed that all of these novel compounds synthesized record the inhibitory effects of acarbose (IC50: 19.32 mM), which acts as a control glycosidase inhibitor. Indeed, the most effective Ki value of CoNPs was 15.70 ± 3.10 mM, respectively. For this metabolic enzyme, IC50 values of ACR as control and novel nanoparticles the following order: CoNPs (11.26 mM, r2: 0.9371) < Co(NO3)2 (15.86 mM, r2: 0.9760) < ACR (19.32 mM, r2: 0.9646). Anti-diabetic drugs that are used in clinical practice, such as acarbose, voglibose and miglitol, competitively inhibit α-glucosidase in brush border of small intestine which subsequently interrupt hydrolysis of carbohydrate and improve postprandial hyperglycemia[62].

Table 10

Inhibition results of nanoparticles (CoNPs) on some metabolic enzymes (IC50 ve Ki values).

Enzymes	α-Gly (mM)	AChE (mM) AChE (mM)	BChE (mM)
Co(NO3)2
IC50	15.86	0.68	1.32
r2	0.9760	0.9654	0.9768
Ki + std	18.51 + 2.73	0.42 ± 0.11	1.18 ± 0.17
CoNPs
IC50	11.26	1.24	2.20
r2	0.9371	0.9139	0.9861
Ki + std	15.70 ± 3.10	1.04 ± 0.24	1.91 ± 0.38
Standards (acarbose for α-Gly, tacrine for AChE and BChE)
IC50	19.32	1.98	3.84
r2	0.9646	0.9883	0.9812
Ki + std	23.21 ± 4.22	1.52 ± 0.41	3.12 ± 0.84

Conclusions

The recent research indicated an ecofriendly, clean and useful method to synthesize cobalt nanoparticles using Z. clinopodioides aqueous extract, in which no chemical substance was used. Due to the existing major problems in the physical and chemical methods for producing nanoparticles, there is a need to easy, low-cost, and non-toxic procedures. FT-IR, UV–Vis spectroscopy, EDS, and FESEM techniques were used to characterize CoNPs synthesized. The synthesized CoNPs have great antioxidant, antifungal, antibacterial, and cutaneous wound healing potentials. Also, the absence of any notable toxicity is another advantage that was evaluated and confirmed by the recent study. After confirming in the clinical trial sutides, this formulation can be used for the treatment of several types of cutaneous wounds in humans.